NYSEAMERICAN:HLTH - Nobilis Health Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.36 0.00 (0.00 %) (As of 03/22/2019 03:59 AM ET)Previous Close$0.3612Today's Range$0.3605 - $0.3752-Week Range$0.17 - $1.70Volume59,432 shsAverage Volume131,313 shsMarket Capitalization$28.21 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Nobilis Health Corp. owns and manages ambulatory surgical centers (ASCs), and acute-care and surgical hospitals in the United States. It operates through two segments, Medical Services and Marketing. The company's healthcare facilities provides surgical procedures in various clinical specialties, including orthopedic surgery, podiatric, vein and vascular, pain management, gastro- intestinal, gynecology, and general, as well as ear, nose, and throat. It also provides marketing services, patient education services, and patient care co-ordination management services to third party facilities and physicians. As of December 4, 2017, it operated 32 locations, including 5 hospitals, 14 ASCs, and 13 multi-specialty clinics. The company was formerly known as Northstar Healthcare Inc. and changed its name to Nobilis Health Corp. in December 2014. Nobilis Health Corp. was founded in 2007 and is based in Houston, Texas. Receive HLTH News and Ratings via Email Sign-up to receive the latest news and ratings for HLTH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Care Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:HLTH Previous SymbolNYSE:HLTH CUSIPN/A CIK1009575 Webwww.northstar-healthcare.com Phone+1-713-3558614Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees700 Outstanding Shares78,250,000Market Cap$28.21 million Next Earnings DateN/A OptionableOptionable Nobilis Health (NYSEAMERICAN:HLTH) Frequently Asked Questions What is Nobilis Health's stock symbol? Nobilis Health trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "HLTH." How were Nobilis Health's earnings last quarter? Nobilis Health Corp (NYSEAMERICAN:HLTH) announced its quarterly earnings data on Thursday, August, 2nd. The healthcare company reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by $0.02. The healthcare company earned $69.19 million during the quarter. View Nobilis Health's Earnings History. What price target have analysts set for HLTH? 1 brokerages have issued 1-year target prices for Nobilis Health's stock. Their predictions range from $2.00 to $2.00. On average, they anticipate Nobilis Health's share price to reach $2.00 in the next year. This suggests a possible upside of 454.8% from the stock's current price. View Analyst Price Targets for Nobilis Health. What is the consensus analysts' recommendation for Nobilis Health? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nobilis Health in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nobilis Health. Has Nobilis Health been receiving favorable news coverage? Media headlines about HLTH stock have trended somewhat positive on Friday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Nobilis Health earned a news sentiment score of 1.3 on InfoTrie's scale. They also assigned news stories about the healthcare company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the company's share price in the near future. Are investors shorting Nobilis Health? Nobilis Health saw a increase in short interest in February. As of February 28th, there was short interest totalling 748,999 shares, an increase of 6.5% from the February 15th total of 703,192 shares. Based on an average daily trading volume, of 73,699 shares, the short-interest ratio is presently 10.2 days. Approximately 1.3% of the shares of the stock are short sold. View Nobilis Health's Current Options Chain. Who are some of Nobilis Health's key competitors? Some companies that are related to Nobilis Health include Assure (IOM), CENTRIC HEALTH (CHH), Konekt (KKT), Brain Resource (BRC), Totally (TLY), Venn Life Sciences (VENN), Agility Health (AHI), Widecells Group (WDC), Amadeus It Group (AMS), Blvd Centers (CXV), Cambian Group (CMBN), CHAMPION PAIN C/SH SH (CPAI), Eviana Health (EHC), Medical Facilities (MFCSF) and Premier Health Group (PHGI). What other stocks do shareholders of Nobilis Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nobilis Health investors own include Chesapeake Energy (CHK), Verastem (VSTM), Micron Technology (MU), Palatin Technologies (PTN), Catalyst Pharmaceuticals (CPRX), Gilead Sciences (GILD), AVEO Pharmaceuticals (AVEO), Nobilis Health (NHC), Hemispherx BioPharma (HEB) and Advanced Micro Devices (AMD). Who are Nobilis Health's key executives? Nobilis Health's management team includes the folowing people: Mr. Harry Joseph Fleming, Chairman (Age 60)Dr. Kenneth D. Efird, Pres (Age 39)Mr. Patrick Yoder, Chief Revenue Officer (Age 41)Dr. Neil Badlani, Chief Medical Officer & Director (Age 40)Ms. Marissa Arreola, Chief Strategy Officer & Pres of Concertis (Age 46) Who are Nobilis Health's major shareholders? Nobilis Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Weber Alan W (0.75%), Perritt Capital Management Inc. (0.51%) and Millennium Management LLC (0.17%). Company insiders that own Nobilis Health stock include Harry Joseph Fleming, Kenneth Efird and Paul David Young. View Institutional Ownership Trends for Nobilis Health. Which major investors are selling Nobilis Health stock? HLTH stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC. View Insider Buying and Selling for Nobilis Health. Which major investors are buying Nobilis Health stock? HLTH stock was bought by a variety of institutional investors in the last quarter, including Weber Alan W and Perritt Capital Management Inc.. Company insiders that have bought Nobilis Health stock in the last two years include Harry Joseph Fleming, Kenneth Efird and Paul David Young. View Insider Buying and Selling for Nobilis Health. How do I buy shares of Nobilis Health? Shares of HLTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Nobilis Health's stock price today? One share of HLTH stock can currently be purchased for approximately $0.3605. How big of a company is Nobilis Health? Nobilis Health has a market capitalization of $28.21 million. Nobilis Health employs 700 workers across the globe. What is Nobilis Health's official website? The official website for Nobilis Health is http://www.northstar-healthcare.com/. How can I contact Nobilis Health? Nobilis Health's mailing address is 11700 Katy Fwy Ste 300, HOUSTON, TX 77079-1218, United States. The healthcare company can be reached via phone at +1-713-3558614. MarketBeat Community Rating for Nobilis Health (NYSEAMERICAN HLTH)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 172 (Vote Outperform)Underperform Votes: 182 (Vote Underperform)Total Votes: 354MarketBeat's community ratings are surveys of what our community members think about Nobilis Health and other stocks. Vote "Outperform" if you believe HLTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HLTH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: Trading Stocks - What are percentage gainers?